Entheon Biomedical Corp (STU:1XU)
€ 0.122 0.0295 (31.89%) Market Cap: 1.45 Mil Enterprise Value: 1.29 Mil PE Ratio: 0 PB Ratio: 6.15 GF Score: 41/100

Entheon Biomedical Corp at Benzinga Global Small Cap Investor Conference (Virtual) Transcript

Dec 08, 2021 - Dec 09, 2021 / NTS GMT
Release Date Price: €3.3 (+3.77%)
Spencer Israel
Benzinga - Executive Producer, BenzingaTV

Let's bring on our next speaker. I see him working backstage. There he is. Timothy Ko, the CEO of Entheon Biomedical, ticker ENTBF here in the US. Timothy, how are we doing today?

Timothy Ko
Entheon Biomedical Corp. - CEO

Absolutely fantastic, a pleasure to be here.

Spencer Israel
Benzinga - Executive Producer, BenzingaTV

Fantastic, a pleasure to have you on. I see your slides. Let's roll, man, the floor is yours.

Timothy Ko
Entheon Biomedical Corp. - CEO

Okay, wonderful. Yes, so I'm Timothy Ko. I'm the CEO of Entheon Biomedical. We're developing a new dimension in addiction treatment. There's the disclaimer language there. So yes, we're developing a personalized system of medicine within the emerging psychedelic therapy industry. Our intention here is to increase the safety and precision in psychedelic therapy using DMT and diagnostic tools.

So at Entheon, we're powered by an unwavering

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot